Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN109824640B discloses a cost-effective 3-step synthesis of coumarin-based BRD4 inhibitors, offering reliable supply chain solutions for oncology drug development.
Patent CN103848757B details high-yield synthesis. Offers supply chain stability and cost efficiency for pharmaceutical manufacturing partners globally.
Patent CN104829460A reveals a cost-effective asymmetric reductive amination route for cinacalcet hydrochloride, offering high purity and scalable pharmaceutical intermediate manufacturing solutions.
Advanced green synthesis of Prilocaine HCl via Patent CN102093248B. Eliminates toxic solvents, ensures high purity, and offers cost-effective scalable manufacturing for global API producers.
Novel synthesis route for benzimidazole intermediates offers improved yield and supply chain stability for global pharmaceutical manufacturing partners.
Patent CN107778252A reveals novel synthesis route for benzimidazoles. Enhances purity and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Novel four-step route for benzimidazole intermediate ensuring high purity and scalable production for pharmaceutical supply chains reducing overall manufacturing complexity significantly.
Patent CN116751172A reveals a novel copper-catalyzed route for diiodo-triazoles, offering cost reduction in pharmaceutical intermediate manufacturing and enhanced supply chain reliability.
Patent CN115448969B reveals high-yield recrystallization technology. Reduces operational cost and improves supply chain reliability for global contraceptive intermediates manufacturing.
Patent CN105985275A reveals stable protecting groups for ezetimibe intermediates. Enhances purity and reduces manufacturing costs for pharmaceutical intermediates supply chains globally.
Patent CN111153862B reveals a novel recrystallization technique for Lesinurad, eliminating critical impurities and ensuring supply chain reliability for API manufacturers.
Patent CN116981659A details a novel Fe-catalyzed route for chiral sulfoxides, offering high purity and cost reduction in pharmaceutical intermediate manufacturing without chiral HPLC.
Novel copper-catalyzed route offers high-purity anti-cancer intermediates with reduced toxicity and scalable manufacturing potential for global supply chains.
Novel solid-liquid phase synthesis for Linaclotide improves purity and yield for scalable pharmaceutical intermediate production ensuring reliable supply chain continuity.
Novel synthesis method for tetrahydropyran-3-boronic acid pinacol ester offers scalable production and cost efficiency for pharmaceutical supply chains.
Novel Pd-catalyzed synthesis of monofluoro 1,4-enynes. Mild conditions, high yield. Reliable supplier for pharma intermediates.
Novel high-pressure formate method for 5-azacytosine improves yield above 70% and purity exceeding 98%, offering significant cost reduction in pharmaceutical intermediates manufacturing.
Patent CN102786429A details a high-yield MIBK-based synthesis of Tolfenamic Acid, offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Novel patent CN119661505A enables safer Resmetirom production with reduced costs and improved supply chain reliability for global pharmaceutical manufacturers.
Patent CN117050024B offers high-yield synthesis for Abacavir intermediates. Reduces phosphorus waste and ensures scalable supply chain continuity for global pharmaceutical manufacturers.